SAPAP3 Inhibitors
SAPAP3, or Synapse-Associated Protein 90/postsynaptic Density-95-Associated Protein 3, is a critical component of the neuronal scaffolding system, essential for the proper formation and function of synaptic junctions in the brain. This protein serves as a binding partner for postsynaptic density proteins and receptors that are crucial for signal transmission across the synapse. The precise expression levels of SAPAP3 are vital for maintaining synaptic stability and plasticity, which are fundamental for cognitive processes such as learning and memory formation. The molecular mechanisms that govern the expression of SAPAP3 are complex and involve an intricate network of transcription factors, epigenetic marks, and feedback loops that ensure its expression is finely tuned to the neuronal environment and activity.
In the realm of molecular biology and biochemistry, several chemical compounds have been identified that can potentially inhibit the expression of proteins like SAPAP3 by interfacing with these regulatory mechanisms. For instance, histone deacetylase inhibitors such as Trichostatin A can alter chromatin accessibility, potentially leading to transcriptional repression of target genes. DNA methyltransferase inhibitors, including 5-Azacytidine and RG108, can induce hypomethylation of gene promoters, which may result in decreased gene expression. Other compounds, such as Mithramycin A, bind directly to DNA, inhibiting the binding of transcriptional machinery. Additionally, transcription can be hindered by intercalators like Actinomycin D, which prevents the advancement of RNA polymerase along the DNA strand. Compounds such as Rapamycin, which inhibit the mTOR signaling pathway, could also decrease the expression of proteins by reducing the transcriptional activity of certain genes. These chemicals represent a diverse array of molecular entities that can interact with the cellular machinery responsible for the regulation of gene expression, and they provide valuable tools for scientists exploring the intricacies of gene regulation in the context of synaptic function and the maintenance of neuronal integrity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, as a histone deacetylase inhibitor, may lead to a more open chromatin structure, potentially resulting in the downregulation of various genes, including SAPAP3, by allowing transcription repressors greater access to the gene's promoter region. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine could decrease the methylation status of the SAPAP3 promoter. This hypomethylation may lead to reduced binding of methyl-CpG-binding proteins and histone deacetylases, culminating in decreased SAPAP3 expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG 108 specifically targets DNA methyltransferases without incorporating itself into the DNA, potentially resulting in promoter demethylation and subsequent transcriptional silencing of the SAPAP3 gene, thereby reducing its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich sequences within DNA, which may include promoter regions of specific genes. By binding to the SAPAP3 promoter, it could prevent the transcriptional machinery from initiating gene expression, leading to a decrease in SAPAP3 levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates between DNA base pairs, preventing RNA polymerase from progressing along the DNA template. This blockade could result in the inhibition of SAPAP3 gene transcription, thereby reducing the expression of the protein. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
By intercalating into DNA, Mitoxantrone can disrupt both transcription and replication processes. This disruption may lead to a decrease in SAPAP3 mRNA synthesis if the SAPAP3 gene region is affected, thereby decreasing the overall expression of the protein. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine may induce DNA hypomethylation, which could activate transcription of genes that encode repressors of the SAPAP3 gene, resulting in decreased expression of SAPAP3. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts the function of hypoxia-inducible factor 1 (HIF-1), which could lead to transcriptional repression of HIF-1 target genes. If SAPAP3 is among those targets, chetomin would contribute to the downregulation of this protein's expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate, a major component of green tea, has been shown to repress the expression of certain genes. If SAPAP3 falls within this category, EGCG could bind to the promoter region of the gene, recruiting histone deacetylases and methyltransferases, leading to a more closed chromatin state and reduced expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 inhibits the extracellular signal-regulated kinase (ERK) pathway, which might be critical for the transcription of certain genes. Inhibition of this pathway could result in decreased transcriptional activity of the SAPAP3 gene, leading to lower protein levels. | ||||||